Related Experiment Videos
Rapid optimization of an ICE inhibitor synthesis using multiple reaction conditions in a parallel array
J S Warmus1, T R Ryder, J C Hodges
1Department of Chemistry, Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, Ann Arbor, MI 48105, USA.
Bioorganic & Medicinal Chemistry Letters
|January 5, 1999
Summary
Researchers optimized a two-step reaction sequence, synthesizing 590 new compounds. Thirty-five compounds demonstrated significantly improved inhibitory activity against N-His (D381E) ICE, advancing drug discovery efforts.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Drug Discovery
Background:
- The development of novel inhibitors for ICE (Interleukin-1β-converting enzyme) is crucial for treating inflammatory diseases.
- Existing inhibitors may lack sufficient potency or specificity.
Purpose of the Study:
- To optimize a two-step reaction sequence for efficient synthesis of novel ICE inhibitors.
- To identify potent inhibitors against N-His (D381E) ICE using combinatorial chemistry.
Main Methods:
- Evaluation of over 200 reaction conditions to optimize a two-step synthesis.
- Application of optimized conditions in combinatorial arrays to generate 590 new compounds.
- Screening of synthesized compounds for inhibitory activity against N-His (D381E) ICE.
Main Results:
- Successful optimization of a two-step reaction sequence within 3-4 days.
- Synthesis of a library of 590 novel chemical entities.
- Identification of 35 compounds with at least a tenfold increase in inhibitory activity compared to the standard.
Conclusions:
- The optimized synthetic route enables rapid generation of diverse compound libraries.
- The identified compounds represent promising leads for further development as ICE inhibitors.
- This approach accelerates the discovery of potent modulators of inflammatory pathways.